Oxidative modification of a specific apolipoprotein B lysine residue confers altered receptor specificity on LDL.
Griffiths
H R
HR
Department of Pharmaceutical Sciences, Aston University, Birmingham, UK. h.r.griffiths@aston.ac.uk
Wright
J
J
Bevan
R
R
Lunec
J
J
D001055:Apolipoproteins B / Q000378:metabolism*; D002478:Cells, Cultured; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008239:Lysine; D010084:Oxidation-Reduction; D011973:Receptors, LDL / Q000378:metabolism*; D013329:Structure-Activity Relationship; D020298:U937 Cells
D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; D011973:Receptors, LDL; D008239:Lysine